Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × disitamab vedotin × Tumor-Agnostic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4 Gastrointestinal 4 Breast 2 Tumor-Agnostic 1 Thoracic 1

Conditions

Interventions

tislelizumab 3 Standard of Care 3 Radiotherapy 3 Oxaliplatin 3 trastuzumab deruxtecan 2 pembrolizumab 2 cemiplimab 2 Radiosurgery 2 Radiation 2 Paclitaxel 2 Data Collection 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 vedolizumab 1 trametinib 1 toripalimab 1 surufatinib 1 sintilimab 1 monalizumab 1 ivosidenib 1 disitamab vedotin 1 coenzyme Q10 1 blinatumomab 1 anlotinib 1 Whole Genome Sequencing 1 Ursodeoxycholic Acid 1 Ultrasonography 1 Tretinoin 1 Thymopentin 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07142200 2025-08-26

DECIDING

RenJi Hospital

Phase 2 Not yet recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡